Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| 1 |
Carvana
CVNA
|
+$854M |
| 2 |
Microsoft
MSFT
|
+$754M |
| 3 |
Apple
AAPL
|
+$503M |
| 4 |
Amazon
AMZN
|
+$465M |
| 5 |
PayPal
PYPL
|
+$392M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$824M |
| 2 |
Invesco Dorsey Wright Momentum ETF
PDP
|
+$607M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$500M |
| 4 |
Boston Scientific
BSX
|
+$214M |
| 5 |
Fidelity High Dividend ETF
FDVV
|
+$211M |
Sector Composition
| 1 | Technology | 22.53% |
| 2 | Financials | 10.32% |
| 3 | Consumer Discretionary | 10.19% |
| 4 | Healthcare | 8.49% |
| 5 | Communication Services | 7.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Ultragenyx Pharmaceutical
RARE
$2.97B
| $4.96M | ﹤0.01% |
58,948
+29,199
| +98% | +$2.46M |
|
1277
Prothena Corp
PRTA
$449M
| $4.95M | ﹤0.01% |
100,288
+47,003
| +88% | +$2.32M |
|
1278
Watts Water Technologies
WTS
$9.37B
| $4.95M | ﹤0.01% |
25,493
+6,703
| +36% | +$1.3M |
|
1279
Cemex
CX
$13.7B
| $4.95M | ﹤0.01% |
729,546
+122,461
| +20% | +$830K |
|
1280
Genesis Energy
GEL
$2.03B
| $4.95M | ﹤0.01% |
461,952
-70,739
| -13% | -$758K |
|
1281
ARK Fintech Innovation ETF
ARKF
$1.37B
| $4.94M | ﹤0.01% |
120,989
-237,038
| -66% | -$9.68M |
|
1282
Yeti Holdings
YETI
$2.92B
| $4.94M | ﹤0.01% |
59,649
-23,723
| -28% | -$1.97M |
|
|
PACW
1283
DELISTED
PacWest Bancorp
PACW
| $4.91M | ﹤0.01% |
108,586
-400,277
| -79% | -$18.1M |
|
1284
Relay Therapeutics
RLAY
$691M
| $4.9M | ﹤0.01% |
159,615
+25,382
| +19% | +$780K |
|
1285
Vanguard Real Estate ETF
VNQ
$34.8B
| $4.9M | ﹤0.01% |
42,193
-20,962
| -33% | -$2.43M |
|
|
GBT
1286
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $4.89M | ﹤0.01% |
167,128
+76,303
| +84% | +$2.23M |
|
|
MNR
1287
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $4.89M | ﹤0.01% |
232,846
-47,549
| -17% | -$999K |
|
1288
Jefferies Financial Group
JEF
$13.7B
| $4.88M | ﹤0.01% |
131,458
-56,394
| -30% | -$2.09M |
|
1289
Vanguard FTSE All-World ex-US ETF
VEU
$49.7B
| $4.87M | ﹤0.01% |
79,514
+9,355
| +13% | +$573K |
|
1290
Abercrombie & Fitch
ANF
$4.2B
| $4.87M | ﹤0.01% |
139,837
+52,137
| +59% | +$1.82M |
|
1291
Editas Medicine
EDIT
$240M
| $4.87M | ﹤0.01% |
183,445
+113,444
| +162% | +$3.01M |
|
|
SPGS
1292
DELISTED
Simon Property Group Acquisition Holdings, Inc.
SPGS
| $4.87M | ﹤0.01% |
500,000
+3
| +0% | +$29 |
|
1293
Apple Hospitality REIT
APLE
$2.97B
| $4.86M | ﹤0.01% |
300,824
-15,600
| -5% | -$252K |
|
1294
Ironwood Pharmaceuticals
IRWD
$206M
| $4.86M | ﹤0.01% |
416,483
+88,336
| +27% | +$1.03M |
|
|
CCXI
1295
DELISTED
ChemoCentryx, Inc.
CCXI
| $4.85M | ﹤0.01% |
133,267
-70,233
| -35% | -$2.56M |
|
|
FTCH
1296
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $4.85M | ﹤0.01% |
145,139
-2,494
| -2% | -$83.4K |
|
1297
Amdocs
DOX
$9.39B
| $4.85M | ﹤0.01% |
64,811
-5,158
| -7% | -$386K |
|
1298
Goodyear
GT
$2.44B
| $4.84M | ﹤0.01% |
226,896
+63,573
| +39% | +$1.36M |
|
1299
Group 1 Automotive
GPI
$6.03B
| $4.81M | ﹤0.01% |
24,640
-2,940
| -11% | -$574K |
|
1300
Arcturus Therapeutics
ARCT
$466M
| $4.81M | ﹤0.01% |
129,824
+65,188
| +101% | +$2.41M |
|